State of Wyoming Boosts Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

State of Wyoming raised its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 169.5% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 25,359 shares of the company's stock after purchasing an additional 15,950 shares during the period. State of Wyoming's holdings in Option Care Health were worth $588,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its holdings in shares of Option Care Health by 29.6% during the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock valued at $35,065,000 after purchasing an additional 344,875 shares during the period. MetLife Investment Management LLC increased its position in Option Care Health by 7.8% in the 4th quarter. MetLife Investment Management LLC now owns 197,219 shares of the company's stock valued at $4,575,000 after buying an additional 14,311 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in Option Care Health by 6.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after buying an additional 147,054 shares during the period. Global Alpha Capital Management Ltd. boosted its holdings in Option Care Health by 38.1% in the fourth quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock worth $1,596,000 after acquiring an additional 18,992 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new position in Option Care Health in the fourth quarter worth approximately $327,000. 98.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on OPCH. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and upped their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Barrington Research restated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a report on Wednesday, April 30th. JPMorgan Chase & Co. lifted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. JMP Securities reissued a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research report on Tuesday, April 22nd. Finally, UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. One research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Stock Down 2.1%

OPCH traded down $0.67 during mid-day trading on Friday, reaching $31.36. 438,584 shares of the stock were exchanged, compared to its average volume of 1,854,181. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a market capitalization of $5.14 billion, a PE ratio of 26.35, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The company has a 50 day moving average price of $33.05 and a two-hundred day moving average price of $29.24.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.04. The business had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm's revenue for the quarter was up 16.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.26 earnings per share. As a group, research analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Activity

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.